Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RF-Vaginale : Randomised Phase III Trial Evaluating the Efficacy and Safety of Vaginal Radiofrequency in the Management of Vulvovaginal Atrophy and Dryness in Patients Treated for Breast Cancer

NCT06900374 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT06900374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06900374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RF-Vaginale : Randomised Phase III Trial Evaluating the Efficacy and Safety of Vaginal Radiofrequency in the Management of Vulvovaginal Atrophy and Dryness in Patients Treated for Breast Cancer
Lead sponsor
Centre Oscar Lambret
Phase
Not applicable
Overall status
Recruiting
Start date
June 12, 2025
Completion date
June 30, 2028
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, vaginal dryness, vulvovaginal atrophy